A Novel AI Framework for Breast Cancer Molecular Biomarker Response Score Detection on Cells Level Using Marker-Based Watershed Segmentation and Machine Learning Classifiers

Breast cancer is a highly complex disease that requires precise molecular subtyping to guide tailored treatment strategies. In this study, we employed a marker-based watershed segmentation technique on a breast cancer dataset, enabling the extraction of essential morphometric parameters. These included area, perimeter, circularity, maximal and minimal calipers, and eccentricity, along with hematoxylin and diaminobenzidine (DAB) staining characteristics for individual cells, nuclei, and cytoplasm. We utilized Support Vector Machine (SVM) and Random Forest (RF) models to classify molecular biomarker response scores to identify their molecular subtypes, leveraging these extracted features as discriminative factors. The dataset comprised whole-slide images (WSI) annotated with Progestin Receptors (PR) molecular biomarker response scores, categorizing cell regions into different classes: "other", "tumor: negative", "tumor: +1", "tumor: +2", and "tumor: +3". These detailed annotations enhanced the AI-driven classification of breast cancer molecular biomarkers response score detection on cell level. Performance evaluation of the proposed framework demonstrated substantial classification accuracy, with SVM achieving over 93% in precision, recall, F1-score, and overall accuracy, while RF exceeded 96% across these metrics. The study's findings highlight the efficacy of integrating marker-based watershed segmentation with morphometric and staining analysis for precise breast cancer molecular biomarkers response score classification. This approach provides deeper insights into tumor heterogeneity, reinforcing the importance of incorporating morphometric and staining parameters in molecular biomarkers response score classification and hence improved personalized treatment and prognosis.